Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO-College of American Pathologists Guideline Update.

Wolff AC, Somerfield MR, Dowsett M, Hammond MEH, Hayes DF, McShane LM, Saphner TJ, Spears PA, Allison KH

Open source

DOI
10.1200/jco.22.02864
Published
2023 Aug 1
Container
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1200/jco.22.02864,
  title = {Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO-College of American Pathologists Guideline Update.},
  author = {Wolff AC and Somerfield MR and Dowsett M and Hammond MEH and Hayes DF and McShane LM and Saphner TJ and Spears PA and Allison KH},
  year = {2023},
  journal = {Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  doi = {10.1200/jco.22.02864},
  url = {https://doi.org/10.1200/jco.22.02864}
}

RIS

TY  - JOUR
TI  - Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO-College of American Pathologists Guideline Update.
AU  - Wolff AC
AU  - Somerfield MR
AU  - Dowsett M
AU  - Hammond MEH
AU  - Hayes DF
AU  - McShane LM
AU  - Saphner TJ
AU  - Spears PA
AU  - Allison KH
PY  - 2023
JO  - Journal of clinical oncology : official journal of the American Society of Clinical Oncology
DO  - 10.1200/jco.22.02864
UR  - https://doi.org/10.1200/jco.22.02864
ER  - 

APA

AC, W., MR, S., M, D., MEH, H., DF, H., LM, M., TJ, S., PA, S., & KH, A. (2023). Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: ASCO-College of American Pathologists Guideline Update.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. https://doi.org/10.1200/jco.22.02864

Source records